David Scadden
Hematology & Oncology · Boston, MANPI 1609829852
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,347,081 of the $2,607,960 with a category attached, or 90.0%. Agios Pharmaceuticals, Inc. accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Among hematology & oncology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $52,159 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Agios Pharmaceuticals, Inc.$2.6M
- AstraZeneca$3K
Across 1 payment — averaging $975.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$975
What the payments were for
- Consulting fees$260,55910%
- Speaking & faculty fees$2,347,08190%
- Travel & lodging$1700%
- Food & beverage$1490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Agios Pharmaceuticals, Inc. | 48 | $2,605,360 |
| AstraZeneca | 2 | $2,600 |
How this compares
$2,607,960 in reported general payments places this provider in the 95th percentile of 374 hematology & oncology providers in Massachusetts.
Other hematology & oncology in Boston
- Sara TolaneyBoston$799K
- Matthew DavidsBoston$693K
- Julio HajdenbergBoston$583K
- Paul RichardsonBoston$523K
- Seth WanderBoston$464K
- Corey CutlerBoston$454K
- Hanny Al-SamkariBoston$412K
- Rupal BhattBoston$380K
- Matthew Vander HeidenBoston$355K
- Daniel DeangeloBoston$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.